X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-04-01 | HRMY | Kapadia Sandip | CFO | S - Sale | $32.54 | -6,987 | 0 | -100% | -$227,386 | ||||||
| D | 2025-03-03 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $32.67 | -4,869 | 0 | -100% | -$159,090 | |||||
| DM | 2025-01-24 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $37.38 | -14,754 | 0 | -100% | -$551,575 | |||||
| D | 2025-01-27 | HRMY | Kapadia Sandip | CFO | S - Sale+OE | $38.05 | -1,775 | 0 | -100% | -$67,547 | |||||
| D | 2025-01-21 | HRMY | Dayno Jeffrey M. | Pres, CEO | S - Sale+OE | $40.13 | -19,293 | 0 | -100% | -$774,245 | |||||
| D | 2025-01-21 | HRMY | Kapadia Sandip | CFO | S - Sale+OE | $40.18 | -25,000 | 0 | -100% | -$1,004,598 | |||||
| DM | 2025-01-16 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $37.51 | -30,598 | 0 | -100% | -$1,147,715 | |||||
| D | 2025-01-15 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $37.01 | -10,507 | 0 | -100% | -$388,841 | |||||
| D | 2025-01-13 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $37.04 | -7,180 | 0 | -100% | -$265,946 | |||||
| M | 2024-11-01 | HRMY | Valor IV Pharma Holdings, LLC | 10% | S - Sale | $30.30 | -4,600,000 | 6,618,033 | -41% | -$139,391,500 | |||||
| M | 2024-11-01 | HRMY | Marshman Fund Trust II | 10% | S - Sale | $30.30 | -4,600,000 | 6,051,120 | -43% | -$139,391,500 | |||||
| D | 2024-10-29 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $40.47 | -21,496 | 0 | -100% | -$870,018 | |||||
| D | 2024-10-01 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $40.19 | -400 | 0 | -100% | -$16,077 | |||||
| D | 2024-09-30 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $40.03 | -35,846 | 0 | -100% | -$1,434,951 | |||||
| D | 2024-09-27 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $40.05 | -200 | 0 | -100% | -$8,009 | |||||
| D | 2024-03-15 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $32.00 | -11,979 | 0 | -100% | -$383,328 | |||||
| D | 2024-03-08 | HRMY | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $32.00 | -194 | 0 | -100% | -$6,208 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |